Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GBA1 | P04062 | 1/20 | 0.45 |
| ▸ | UGCG | Q16739 | 1/20 | 0.45 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3848824 | 1.00 | CYP3A4 (0.52) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL6685337 | 1.00 | CYP3A4 (0.52) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL3899771 | 0.98 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL11780735 | 0.96 | CYP3A4 (0.58) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL11773965 | 0.96 | CYP3A4 (0.58) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL11777224 | 0.96 | CYP3A4 (0.58) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL2553632 | 0.94 | CYP3A4 (0.58) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL31012427 | 0.94 | CYP3A4 (0.58) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL11774957 | 0.93 | CYP3A4 (0.51) | CYP3A4TSHRALDH1A1TRPV1HPGD | |
| SCHEMBL11773614 | 0.93 | CYP3A4 (0.51) | CYP3A4TSHRALDH1A1TRPV1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101390852-B | Melanogenesis inhibitor and skin preparation containing the same | TAKASAGO PERFUMERY CO LTD | 2010-12-08 | — | — | CN | disclosed |
| CN-1747711-B | Melanogenesis inhibitor and skin preparation containing the same | TAKASAGO PERFUMERY CO LTD | 2010-04-28 | — | — | CN | disclosed |
| US-7576125-B2 | Melanogenesis inhibitor and skin preparation containing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-18 | — | — | US | disclosed |
| CN-101390852-A | Melanogenesis inhibitor and skin preparation containing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2009-03-25 | — | — | CN | disclosed |
| US-20060088485-A1 | Melanogenesis inhibitor and skin preparation containing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-04-27 | — | — | US | disclosed |
| CN-1747711-A | Melanogenesis inhibitor and skin preparation containing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2006-03-15 | — | — | CN | disclosed |
| WO-2004071481-A1 | MELANOGENESIS INHIBITOR AND SKIN PREPARATION CONTAINING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060088485-A1 | Melanogenesis inhibitor and skin preparation containing the same | MC1R, TYR, MITF | CYP3A4 2316/4885TSHR 2223/4885ALDH1A1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.